Princeton Junction, NJ, United States of America

Paul R Meers

This inventor holds 7 USPTO granted patents, plus 2 CIPO patents. Top assignees: The Liposome Company, Inc., Transave Limited, Elan Pharmaceuticalstechnologies, Inc.. Active years: 2000-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul R Meers. Retrieved from https://idiyas.com/inventor/paul-r-meers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 85.7


Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 249(Granted Patents)


Location History:

  • Princeton, NJ (US) (2002)
  • Princeton Junction, NJ (US) (2000 - 2009)

Company Filing History:


Years Active: 2000-2009

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paul R. Meers

Introduction

Paul R. Meers is a notable inventor based in Princeton Junction, NJ, with a significant portfolio of seven patents. His work primarily focuses on advancements in liposomal delivery systems, which have important applications in the field of biomedicine.

Latest Patents

Among his latest patents is the invention titled "Encapsulation of Bioactive Complexes in Liposomes." This invention provides a method to prepare liposome-encapsulated bioactive agents, such as nucleic acids. It involves the complexation of bioactive agents in reverse micelles prior to forming liposomes, along with methods for using these liposomes to deliver nucleic acids to cells. Another significant patent is the "Modular Targeted Liposomal Delivery System." This patent describes a liposome that includes a fusogenic liposome, a linking moiety, and a targeting moiety. The fusogenic liposome encapsulates contents within a lipid bilayer, while the linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety.

Career Highlights

Throughout his career, Paul R. Meers has worked with prominent companies in the pharmaceutical and biotechnology sectors, including The Liposome Company, Inc. and Transave Limited. His contributions to these organizations have been instrumental in advancing liposomal technology.

Collaborations

Paul has collaborated with notable professionals in his field, including Andrew S. Janoff and Charles Pak. Their combined expertise has furthered the development of innovative liposomal delivery systems.

Conclusion

Paul R. Meers is a distinguished inventor whose work in liposomal technology has made significant contributions to biomedicine. His patents reflect a commitment to advancing methods for delivering bioactive agents effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…